Forbion Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 16

Professionals
  • Investments
  • 163

  • Portfolio
  • 34

  • Exits
  • 78

Exits

Forbion General Information

Description

Founded in 2006, Forbion is a venture capital firm headquartered in Naarden, Netherlands. The firm is a signatory to the United Nations Principles for Responsible Investment. Besides financial objectives, the firm selects investments that will positively affect the health and well-being of patients. The firm also operates a joint venture with BioGeneration Ventures, which manages three separate seed and early-stage funds focused on Benelux and Germany.

Contact Information

Website
www.forbion.com
Year Founded
2006
Investor Status
Actively Seeking New Investments
Trade Association
Dutch Venture Capital Association (NVP)
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Impact Investing
Primary Office
  • PO Box 5187
  • 1410 AD Naarden
  • Netherlands
+31 035 000 0000

Forbion Investments (163)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
VectivBio 29-Jun-2022 PIPE 0000 Biotechnology Generating Revenue
00000000 12-Apr-2022 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 00000-000 000000 00
00000000 16-Mar-2022 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 000000 000 00.0
0000000000 0000000 09-Mar-2022 00000 00000 00.000 Drug Discovery Generating Revenue 00000-000 000000 00
0000000000 0000000 23-Feb-2022 0000 00000 00.000 Biotechnology Generating Revenue
0000000 23-Dec-2021 00000 00000 00000 Drug Discovery Generating Revenue 000000 000 00.0
00000 000000 20-Dec-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 00000-000 000000 00
00000000 000000000 17-Dec-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 000000 00000000
Rectify (Drug Discovery) 14-Oct-2021 Early Stage VC 0000 Drug Discovery Generating Revenue 00000 0000000 00.0
Oxitope Pharma 20-Aug-2021 Seed Round 00.000 Pharmaceuticals Startup 00000 0000000 00.0
You’re viewing 10 of 163 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Forbion Exits (78)

Company Name Exit Date Exit Type Exit Size
Gyroscope 22-Feb-2022 Merger/Acquisition 00000
0000000 00000000 0 10-Dec-2021 000 00000
00000000 000000000 31-Mar-2021 000 00000
0000 000000000000 21-Jan-2021 000000 0000000000 00000
0000000000 0000000 07-Oct-2020 000000000 00000 00 000.00
000000000 18-Sep-2020 000000000000000000 00000
0000 000000000000 17-Sep-2020 000 00000
00000 000000000000 09-Sep-2020 000000000000000000 00000
Promedior 13-Feb-2020 Merger/Acquisition 00000
Ario Pharma 01-Oct-2019 Out of Business
You’re viewing 10 of 78 exits. Get the full list »

Forbion Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Forbion‘s full profile, request access.

Request a free trial

Forbion Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Forbion Team (46)

Name Title Deals Funds Boards Office
Vincent Van Houten Chief Financial Officer & General Partner 0 0 0 Naarden, Netherlands
Martien van Osch Co-Founding Partner & Managing Partner 00 0 0 Naarden, Netherlands
Geert-Jan Mulder MD Managing Partner and Co-Founding Partner 00 0 0 Naarden, Netherlands
Sander Slootweg Co-Founder & Managing Partner & Board Member 0 0 0 Naarden, Netherlands
Holger Reithinger Ph.D General Partner 00 0 0 Munich, Germany
You’re viewing 5 of 46 team members. Get the full list »

Forbion Co-Investors (115)

Name With Exits Lead Partner Series Industry
BioGeneration Ventures 6 0 Series chart Industry bar
Novartis Venture Fund 0 0 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
Fountain Healthcare Partners 0 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
You’re viewing 5 of 115 co-investors. Get the full list »